ABH Healthcare Limited (ABH)
Snapshot
The board meets on 12 Nov 2026 to consider the Q2 FY27 results.
Exchange activity4 Nov 2026
- Delivery
- 76.92% vs 80.95% average
- Volume vs its average
- 0.5×
- Bulk & block deals
- 3 in 60 days
- Price band
- 8 band closes in ~20 sessions
Events
- Next results
- 12 Nov 2026 (Q2 FY27)
Exchange data. Each figure as its own page shows it; the dates are the data's. Information only, not investment advice.
📈 Share price & events
Q2 FY27 results
📅 Next results: 12 Nov 2026 (board meeting)ABH Healthcare Limited's board meets on 12 Nov 2026 to consider its Q2 FY27 results (July-September 2026).
ABH delivery percentage and bulk deals
NSE end-of-day data for
On Wed, 4 Nov 2026, 76.92% of the ABH shares traded on NSE were taken to delivery, against the stock's own 20-session average of 80.95%. That is close to its usual level. Turnover was only ₹6 lakh, so a handful of trades can move this figure. Volume was 0.5 times its average, well below normal. It closed at a price band (circuit) on 8 sessions in about the last 20. 3 bulk or block deals were reported in ABH in the last 60 days: ₹0.38 Cr bought and ₹0.37 Cr sold.
Delivery in the last 5 sessions: 64.3% · 88.9% · 72.7% · 66.7% · 76.9%
| Date | Side | Counterparty | Value | Price | Quantity | Type |
|---|---|---|---|---|---|---|
| 21 Oct | Sell | Rikhav Securities Limited | ₹0.37 Cr | ₹42.08 | 88,800 | Bulk |
| 21 Oct | Buy | Sidhachakra Enterprise Llp | ₹0.37 Cr | ₹42.07 | 87,600 | Bulk |
| 21 Oct | Buy | Rikhav Securities Limited | ₹0.01 Cr | ₹41.78 | 2,400 | Bulk |
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
ABH Healthcare Limited's Board of Directors met on October 12, 2026, to approve statutory secretarial appointments. The company appointed Mr. Nikunj Goel (ICSI Membership No. A79297) as the Company Secretary and Compliance Officer (KMP) effective October 12, 2026. Additionally, M/s Jaspreet Dhawan & Associates was appointed as the Secretarial Auditor for FY 2026-27. The meeting was held from 3:30 p.m. to 4:30 p.m. IST.
- Appointment of Mr. Nikunj Goel (Membership No. A79297) as CS and Compliance Officer effective October 12, 2026
- Appointment of M/s Jaspreet Dhawan & Associates (M.No: 9372; CP: 8545) as Secretarial Auditor for FY 2026-27
- Board meeting commenced at 3:30 p.m. IST and concluded at 4:30 p.m. IST on October 12, 2026
ABH Healthcare Limited responded to an NSE surveillance query dated September 17, 2026, regarding significant price movement in its security. The company clarified that it has adhered to Regulation 30 disclosure requirements and holds no pending unpublished price-sensitive information (UPSI). Management stated that the recent trading activity and share price movement are purely market-driven.
- Responded to NSE surveillance query reference NSE/CM/Surveillance/17559 dated September 17, 2026
- Confirmed full compliance with Regulation 30 of SEBI LODR Regulations, 2015
- Clarified no pending UPSI or unannounced operational events exist to explain price movement
ABH Healthcare Limited has entered into a Memorandum of Understanding (MoU) on September 17, 2026, to take over Sri Kailash Multi Speciality Hospital in Sri Ganganagar, Rajasthan, on a lease-and-manage basis. The facility is a 50-bed multi-specialty hospital, and the proposed lease tenure is 15 years with a 3-year lock-in period. The arrangement is non-binding until definitive agreements are signed following due diligence, with a planned takeover date on or before October 31, 2026. Financial consideration details are yet to be mutually decided between the parties.
- Addition of an operational 50-bed multi-specialty hospital in Sri Ganganagar, Rajasthan
- Lease period structured for 15 years with an initial 3-year lock-in period
- Target takeover date scheduled on or before October 31, 2026
- MoU is currently non-binding pending satisfactory completion of due diligence and definitive agreements
ABH Healthcare Limited has completed the repayment of ₹17.00 crore in outstanding borrowings using net proceeds from its recent Initial Public Offering (IPO). This utilisation corresponds to 100% of the ₹17.00 crore allocated for debt repayment as detailed in its Prospectus dated August 27, 2026. The company confirmed that there has been no deviation or variation from the stated objects of the issue.
- Repaid outstanding borrowings aggregating to ₹17.00 crore using IPO proceeds
- Utilised 100% of the ₹17,00,00,000 allocated for debt repayment in the Prospectus
- Follows the objects outlined in the Red Herring Prospectus dated August 13, 2026 and Prospectus dated August 27, 2026
- Confirmed zero deviation or variation in the use of issue proceeds
Company profile
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
